Loading... Loading...

CONNECT to DAVID

David Ewing Duncan

Contributor

DAVID EWING DUNCAN is the author of seven books published in 19 languages, including the worldwide bestseller Calendar, and the recently released bestseller Experimental Man: What one man’s body reveals about his future, your health, and our toxic world.

He is Chief Correspondent of public radio's Biotech Nation, a contributor to Fortune, and a columnist for MIT Technology Review. He is also the Director of the Center of Life Science Policy at UC Berkeley. He has been a contributing editor for Wired, Discover and Conde Nast Portfolio, and also writes for The New York Times, National Geographic, Harper’s, The Atlantic, the San Francisco Chronicle, and many other publications.

He is a former special correspondent and producer for ABC Nightline and a correspondent for NOVA’s ScienceNOW! He has won numerous awards including the Magazine Story of the Year from the American Association for the Advancement of Science. His articles have twice been cited in nominations for National Magazine Awards, and his work has appeared twice in The Best American Science and Nature Writing. He is a graduate of Vassar College and now lives in San Francisco.

Recent Posts

Life At All Costs

Posted: 12/15/2011 12:31:00 PM

Read More
Bionic Eyes That Can Help the Blind See

Posted: 6/24/2011 12:00:00 AM

What if I told you that a device exists that uses a mini-camera embedded in a pair of glasses to feed images directly into the brain of a blind person? And what if this device could earn hund…

Read More
Cars with Brains: Boosting the IQ of Automobiles

Posted: 6/8/2011 12:48:00 PM

Imagine traffic one day behaving like dense schools of fish, which turn and maneuver in a synchronized flash of color without collisions, confusion, or delays. Fish have a natural system of sensor…

Read More
Investment Idea #3: Rewiring the Sun

Posted: 5/18/2011 1:00:00 PM

Overall Rating: (Out of 5 stars: See how we rate this innovation at the end of this article) Minnesota is not known for its endless days of sunshine. But it s…

Read More
New Drugs at Lower Costs--Investing in Growth

Posted: 4/6/2011 12:46:00 PM

In 1996, a patient In a North Carolina hospital was given antibiotics for an infection that had been treated successfully for years.  But this time, the drugs didn’t work.  Soon, the new sup…

Read More
Green Crude: Can Algae End Our Oil Addiction?

Posted: 3/8/2011 2:30:00 PM

This is the first in a series of columns that will report on 100 great ideas for innovation in America and around the world — how they are being funded and by whom, or whether the idea…

Read More

Facebook Turns Friends into Investors

Video
More

Facebook IPO: Who's Getting Rich